These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21374636)

  • 21. Current controversies in prenatal diagnosis 3: is conventional chromosome analysis necessary in the post-array CGH era?
    Bui TH; Vetro A; Zuffardi O; Shaffer LG
    Prenat Diagn; 2011 Mar; 31(3):235-43. PubMed ID: 21374637
    [No Abstract]   [Full Text] [Related]  

  • 22. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population.
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialard F; Giudicelli Y; Ville Y
    Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antenatal screening for Down's syndrome.
    Smith L
    Mod Midwife; 1995 Jun; 5(6):23-6. PubMed ID: 7788401
    [No Abstract]   [Full Text] [Related]  

  • 25. Which contingent sequential screening protocol?
    Larsen SO; Christiansen M; Norgaard-Pedersen B
    Prenat Diagn; 2005 Dec; 25(12):1168-9; author reply 1169-70. PubMed ID: 16317663
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prenatal screening for Down syndrome: from sequential to combined estimated risk].
    Jouannic JM; Benifla JL
    Gynecol Obstet Fertil; 2006 Jun; 34(6):467-9. PubMed ID: 16716636
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antenatal screening methods for chromosome 21 trisomy].
    Päkkilä M; Niemimaa M; Kirkinen P; Ryynänen M
    Duodecim; 2001; 117(3):269-74; quiz 274, 281. PubMed ID: 12092395
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening for Down's syndrome. Conclusions do not reflect reality.
    Reynolds T
    BMJ; 2002 Jan; 324(7329):111. PubMed ID: 11808522
    [No Abstract]   [Full Text] [Related]  

  • 29. Prenatal screening for Down's syndrome.
    Gocze PM; Arany A; Freeman DA
    N Engl J Med; 1992 Dec; 327(27):1951; author reply 1952-3. PubMed ID: 1280772
    [No Abstract]   [Full Text] [Related]  

  • 30. Down syndrome screening: determining the cutoff level of risk for invasive testing.
    Schielen PC; Wildschut HI; Loeber JG
    Prenat Diagn; 2009 Feb; 29(2):190-2. PubMed ID: 19180631
    [No Abstract]   [Full Text] [Related]  

  • 31. [Down syndrome--is it a disease or not?].
    Nau JY
    Rev Med Suisse; 2011 Jun; 7(300):1382-3. PubMed ID: 21815542
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening for Down's syndrome. Modelling does not predict reality accurately.
    Howe D
    BMJ; 2002 Jan; 324(7329):111-2. PubMed ID: 11808523
    [No Abstract]   [Full Text] [Related]  

  • 33. Antenatal screening for Down syndrome.
    Wald NJ
    Prog Clin Biol Res; 1995; 393():27-42. PubMed ID: 8545455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal screening for birth defects: an update.
    Morris K
    Mo Med; 2004; 101(2):121-4. PubMed ID: 15119110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Has prenatal screening influenced the prevalence of comorbidities associated with Down syndrome and subsequent survival rates?
    Halliday J; Collins V; Riley M; Youssef D; Muggli E
    Pediatrics; 2009 Jan; 123(1):256-61. PubMed ID: 19117890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for Down's syndrome. Ratio of femoral length to tibial length needs to be evaluated extensively.
    Sachdev P; Bahl S; Puliyel JM
    BMJ; 2002 Jan; 324(7329):112. PubMed ID: 11808524
    [No Abstract]   [Full Text] [Related]  

  • 37. First- and second-trimester evaluation of risk for Down syndrome.
    Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
    Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for Down's syndrome. Serum screening programmes are effective and safe.
    Wald NJ; Hackshaw AK; Huttly W
    BMJ; 2000 Sep; 321(7263):763-4; author reply 764-5. PubMed ID: 10999927
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of second-trimester serum screening in the post-first-trimester screening era.
    Shamshirsaz AA; Benn P; Egan JF
    Clin Lab Med; 2010 Sep; 30(3):667-76. PubMed ID: 20638580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
    Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
    Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.